IGHE and Alzheimer disease: Thus, future investigations are required to better characterize, among others, the long-term effects and cost–benefit (approximately 6,000 euro for a reusable TheraSorb®-IgE adsorber column pair allowing for up to 10 treatment sessions) of IA in AD, for which more optimized treatment protocols still need to be defined.